Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Titel:
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Auteur:
Vermeire, Severine Lakatos, Peter L Ritter, Timothy Hanauer, Stephen Bressler, Brian Khanna, Reena Isaacs, Kim Shah, Saumin Kadva, Alysha Tyrrell, Helen Oh, Young S Tole, Swati Chai, Akiko Pulley, Jennifer Eden, Christopher Zhang, Wenhui Feagan, Brian G